▶ 調査レポート

無血清培地の世界市場

• 英文タイトル:Global Market Study on Serum-Free Media: Chinese Hamster Ovary Cell Culture to Remain Dominant Media Type Through 2026

Persistence Market Researchが調査・発行した産業分析レポートです。無血清培地の世界市場 / Global Market Study on Serum-Free Media: Chinese Hamster Ovary Cell Culture to Remain Dominant Media Type Through 2026 / B10PMR54資料のイメージです。• レポートコード:B10PMR54
• 出版社/出版日:Persistence Market Research / 2018年9月20日
• レポート形態:英文、PDF、188ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:ライフサイエンス・転換期医療
• 販売価格(消費税別)
  Individual(1名、印刷不可)¥539,000 (USD4,900)▷ お問い合わせ
  Multi User(5名)¥836,000 (USD7,600)▷ お問い合わせ
  Corporate User¥1,166,000 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、無血清培地の世界市場について調べ、無血清培地の世界規模、市場動向、市場環境、培地の種類別(タンパク質発現培地、幹細胞用培地、ハイブリドーマ培地、初代細胞培地、昆虫細胞培地、免疫細胞用培地、チャイニーズハムスター卵巣細胞培養培地、化学的に明確な培地)分析、エンドユーザー別(バイオ医薬品企業、臨床研究機関、学術研究センター)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、関連企業情報などをまとめた調査レポートです。
・エグゼクティブサマリー
・調査手法
・無血清培地の世界市場環境
・無血清培地の世界市場動向
・無血清培地の世界市場規模
・無血清培地の世界市場規模:培地の種類別(タンパク質発現培地、幹細胞用培地、ハイブリドーマ培地、初代細胞培地、昆虫細胞培地、免疫細胞用培地、チャイニーズハムスター卵巣細胞培養培地、化学的に明確な培地)
・無血清培地の世界市場規模:エンドユーザー別(バイオ医薬品企業、臨床研究機関、学術研究センター)
・無血清培地の世界市場:地域別市場規模・分析
・無血清培地の北米市場規模・予測
・無血清培地のアメリカ市場規模・予測
・無血清培地のヨーロッパ市場規模・予測
・無血清培地のアジア市場規模・予測
・関連企業情報・競争状況

This Persistence Market Research (PMR) report examines the “Global Serum-free media Market’ for the period 2018–2026”. The primary objective of the report is to offer updates and information related to market opportunities in the global serum-free media market.

The Global Serum-free media Market is Segmented Based on:

Media Type
End User
Region
This report covers the global serum-free media market performance in terms of revenue contribution from various segments. The report begins with an overview and market definitions. The market viewpoint section underlines the macro-economic factors influencing the growth of the global serum-free media market along with detailing the opportunity analysis of the market. This is then followed by the key drivers, restraints and trends of the global serum-free media market.

By media type, the global serum-free media market is segmented into protein expression media, stem cell media, hybridoma media, primary cell media, insect cell media, immunology media, Chinese hamster cell (CHO) culture media and chemically defined media. The CHO cell culture media is expected to be the dominant segment in the global serum-free media market due to wide use in therapeutic protein production. The CHO cell culture media in serum-free media is high in North America and Europe due to high number of biopharmaceutical companies in the region. Whereas, chemically defined media in serum-free media remains least lucrative segment.

By end users, the global serum-free media market is segmented into biopharmaceutical companies, clinical research organizations and academic research centers.

By region, the global serum-free media market has been segmented into North America (the U.S. & Canada), Latin America (Brazil, Mexico, and Rest of Latin America), Europe (Germany, France, the U.K., Italy, Spain, Russia and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand and Rest of Asia Pacific), and Middle East and Africa (GCC Countries, South Africa, Israel and Rest of MEA).

A detailed analysis has been provided for each region in terms of serum-free media market size, Y-o-Y growth rate, absolute $ opportunity, and attractive index. The forecast of the serum-free media market by country, media type and end user is represented in a tabular form. This section will help to understand the present scenario and opportunity of the serum-free media market in major countries by each segment.

In the next section of the report, the “Competitive Landscape” is included to provide report audiences with a dashboard view of the key competitor firms in order to access the key differentiators among the competitor firms. This section is primarily designed to provide clients with an objective and detailed comparative assessment of product offerings and strategies of key providers specific to a segment. The detailed profiles of players operating in the serum-free media market are also provided in the report, which highlight company description, product/segment overview, SWOT analysis, financial information, key developments related to the serum-free media market and the strategic overview.

The next section of the report highlights the serum-free media market outlook for 2018–2026 and sets the forecast within the context of the serum-free media market by region.

The above sections – by media type and end user – evaluate the historic market analysis and growth prospects of the serum-free media market for the period 2018–2026. We have considered 2017 as the base year and provided data for the forecast period.

The final section of the report represents the global scenario of the serum-free media market along with y-o-y growth and market forecast till 2026. This section also evaluates the global serum-free media market opportunity over the forecast period as well as the absolute dollar opportunity for each year. This section will help to understand the overall market growth for serum-free media and the opportunity analysis for every year over the forecast period.

To arrive at the serum-free media market size, bottom-up approach is used to validate the total market size obtained for the serum-free media market. The forecast presented in the report provides total revenue of the serum-free media market over 2018–2026. PMR uses the triangulation methodology, which is primarily based on experimental techniques such as patient-level data to obtain precise market estimations for the serum-free media market and insights on specific country/regions. The country-specific data is again analyzed to derive data at a regional level and then at a global level. This methodology ensures high quality and accuracy of information.

The factors considered while developing the estimates of the serum-free media market are epidemiology, treatment seeking rate, ratio of population prescribed with different serum-free media.

On the other hand PMR has also analyzed the serum-free media market by considering the revenue from the key players operating in the market. The key players are segmented at a Tier-level with respect to their revenues, product portfolio and geographical presence. This process involves analysis of annual reports of various companies, investor presentations, SEC filings, 10k reports, earning call transcripts and press releases. This task is done to fetch substantial information about the key players, their respective revenues and estimate their respective market share.

The revenue growth of the key players in serum-free media market is analyzed over the historical period and qualitative assessment of new product launches and innovations has been made in order to validate and align the resultant serum-free media market numbers. The market structure is closely studied and analyzed at a regional level to map and ascertain incremental $ opportunity for companies, for instance, supply from domestic/regional players, small-scale enterprises or unorganized segments is also taken into consideration to arrive at the final market numbers.

While forecasting the market size for the serum-free media market, we have considered the impact of several factors such as per capital healthcare expenditure, disposable income, new serum-free media products and approvals for new advanced serum-free media products, penetration of serum-free media products to various end users across all regions, among others. However, quantifying the serum-free media market across the aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities rather than rationalizing them after the forecast has been completed. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the serum-free media market and to identify the right growth opportunities in the global serum-free media market.

レポート目次

1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune

2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy

3. Serum-Free Media Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis

4. Market Background
4.1. Political Outlook
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Trends

5. Global Economic Outlook
5.1. Gross Domestic Product by Region & Country, 2016 – 2021

6. North America Serum-Free Media Market Analysis 2013–2017 and Forecast 2018–2026
6.1. Introduction
6.2. Historical Market Value (US$ Mn) Trend Analysis By Country, 2013–2017
6.2.1. U.S.
6.2.2. Canada
6.3. Market Value (US$ Mn) Forecast By Country, 2018–2026
6.4. Historical Market Value (US$ Mn) & Volume Analysis By Media Type, 2013–2017
6.4.1. Protein Expression Media
6.4.2. Stem Cell Media
6.4.3. Hybridoma Media
6.4.4. Primary Cell Media
6.4.5. Insect Cell Media
6.4.6. Immunology Media
6.4.7. Chinese Hamster Ovary Cell Culture Media
6.4.8. Chemically Defined Media
6.5. Market Value (US$ Mn) & Volume Forecast By Media Type, 2018–2026
6.6. Historical Market Value (US$ Mn) Trend Analysis By End User, 2013–2017
6.6.1. Biopharmaceutical Companies
6.6.2. Clinical Research Organizations
6.6.3. Academic Research Centers
6.7. Market Value (US$ Mn) Forecast By End User, 2018–2026
6.8. Market Attractiveness Analysis
6.8.1. By Country
6.8.2. By Media Type
6.8.3. By End User
6.9. Drivers and Restraints – Impact Analysis

7. Latin America Serum-Free Media Market Analysis 2013–2017 and Forecast 2018–2026
7.1. Introduction
7.2. Historical Market Value (US$ Mn) Trend Analysis By Country, 2013–2017
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Mexico
7.2.4. Rest of Latin America
7.3. Market Value (US$ Mn) Forecast By Country, 2018–2026
7.4. Historical Market Value (US$ Mn) & Volume Analysis By Media Type, 2013–2017
7.4.1. Protein Expression Media
7.4.2. Stem Cell Media
7.4.3. Hybridoma Media
7.4.4. Primary Cell Media
7.4.5. Insect Cell Media
7.4.6. Immunology Media
7.4.7. Chinese Hamster Ovary Cell Culture Media
7.4.8. Chemically Defined Media
7.5. Market Value (US$ Mn) & Volume Forecast By Media Type, 2018–2026
7.6. Historical Market Value (US$ Mn) Trend Analysis By End User, 2013–2017
7.6.1. Biopharmaceutical Companies
7.6.2. Clinical Research Organizations
7.6.3. Academic Research Centers
7.7. Market Value (US$ Mn) Forecast By End User, 2018–2026
7.8. Market Attractiveness Analysis
7.8.1. By Country
7.8.2. By Media Type
7.8.3. By End User
7.9. Drivers and Restraints – Impact Analysis

8. Europe Serum-Free Media Market Analysis 2013–2017 and Forecast 2018–2026
8.1. Introduction
8.2. Historical Market Value (US$ Mn) Trend Analysis By Country, 2013–2017
8.2.1. Germany
8.2.2. U.K.
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Market Value (US$ Mn) Forecast By Country, 2018–2026
8.4. Historical Market Value (US$ Mn) & Volume Analysis By Media Type, 2013–2017
8.4.1. Protein Expression Media
8.4.2. Stem Cell Media
8.4.3. Hybridoma Media
8.4.4. Primary Cell Media
8.4.5. Insect Cell Media
8.4.6. Immunology Media
8.4.7. Chinese Hamster Ovary Cell Culture Media
8.4.8. Chemically Defined Media
8.5. Market Value (US$ Mn) & Volume Forecast By Media Type, 2018–2026
8.6. Historical Market Value (US$ Mn) Trend Analysis By End User, 2013–2017
8.6.1. Biopharmaceutical Companies
8.6.2. Clinical Research Organizations
8.6.3. Academic Research Centers
8.7. Market Value (US$ Mn) Forecast By End User, 2018–2026
8.8. Market Attractiveness Analysis
8.8.1. By Country
8.8.2. By Media Type
8.8.3. By End User
8.9. Drivers and Restraints – Impact Analysis

9. Middle East & Africa Serum-Free Media Market Analysis 2013–2017 and Forecast 2018–2026
9.1. Introduction
9.2. Historical Market Value (US$ Mn) Trend Analysis By Country, 2013–2017
9.2.1. GCC Countries
9.2.2. South Africa
9.2.3. Rest of MEA
9.3. Market Value (US$ Mn) Forecast By Country, 2018–2026
9.4. Historical Market Value (US$ Mn) & Volume Analysis By Media Type, 2013–2017
9.4.1. Protein Expression Media
9.4.2. Stem Cell Media
9.4.3. Hybridoma Media
9.4.4. Primary Cell Media
9.4.5. Insect Cell Media
9.4.6. Immunology Media
9.4.7. Chinese Hamster Ovary Cell Culture Media
9.4.8. Chemically Defined Media
9.5. Market Value (US$ Mn) & Volume Forecast By Media Type, 2018–2026
9.6. Historical Market Value (US$ Mn) Trend Analysis By End User, 2013–2017
9.6.1. Biopharmaceutical Companies
9.6.2. Clinical Research Organizations
9.6.3. Academic Research Centers
9.7. Market Value (US$ Mn) Forecast By End User, 2018–2026
9.8. Market Attractiveness Analysis
9.8.1. By Country
9.8.2. By Media Type
9.8.3. By End User
9.9. Drivers and Restraints – Impact Analysis

10. Competition Landscape
10.1. Market Structure by Tier of Companies
10.2. Competition Dashboard
10.3. Company Deep Dive
10.3.1. Thermo Fisher Scientific Inc.
10.3.1.1. Overview
10.3.1.2. Product and Application Portfolio
10.3.1.3. Production Footprint
10.3.1.4. Sales Footprint
10.3.1.5. Channel Footprint
10.3.1.6. Strategy
10.3.1.6.1.1. Marketing Strategy
10.3.1.6.1.2. Product Strategy
10.3.1.6.1.3. Channel Strategy
10.3.2. Merck KGaA
10.3.2.1. Overview
10.3.2.2. Product and Application Portfolio
10.3.2.3. Production Footprint
10.3.2.4. Sales Footprint
10.3.2.5. Channel Footprint
10.3.2.6. Strategy
10.3.2.6.1.1. Marketing Strategy
10.3.2.6.1.2. Product Strategy
10.3.2.6.1.3. Channel Strategy
10.3.3. GE Healthcare
10.3.3.1. Overview
10.3.3.2. Product and Application Portfolio
10.3.3.3. Production Footprint
10.3.3.4. Sales Footprint
10.3.3.5. Channel Footprint
10.3.3.6. Strategy
10.3.3.6.1.1. Marketing Strategy
10.3.3.6.1.2. Product Strategy
10.3.3.6.1.3. Channel Strategy
10.3.4. Lonza
10.3.4.1. Overview
10.3.4.2. Product and Application Portfolio
10.3.4.3. Production Footprint
10.3.4.4. Sales Footprint
10.3.4.5. Channel Footprint
10.3.4.6. Strategy
10.3.4.6.1.1. Marketing Strategy
10.3.4.6.1.2. Product Strategy
10.3.4.6.1.3. Channel Strategy
10.3.5. Corning Incorporated
10.3.5.1. Overview
10.3.5.2. Product and Application Portfolio
10.3.5.3. Production Footprint
10.3.5.4. Sales Footprint
10.3.5.5. Channel Footprint
10.3.5.6. Strategy
10.3.5.6.1.1. Marketing Strategy
10.3.5.6.1.2. Product Strategy
10.3.5.6.1.3. Channel Strategy
10.3.6. Irvine Scientific
10.3.6.1. Overview
10.3.6.2. Product and Application Portfolio
10.3.6.3. Production Footprint
10.3.6.4. Sales Footprint
10.3.6.5. Channel Footprint
10.3.6.6. Strategy
10.3.6.6.1.1. Marketing Strategy
10.3.6.6.1.2. Product Strategy
10.3.6.6.1.3. Channel Strategy
10.3.7. STEMCELL Technologies Inc.
10.3.7.1. Overview
10.3.7.2. Product and Application Portfolio
10.3.7.3. Production Footprint
10.3.7.4. Sales Footprint
10.3.7.5. Channel Footprint
10.3.7.6. Strategy
10.3.7.6.1.1. Marketing Strategy
10.3.7.6.1.2. Product Strategy
10.3.7.6.1.3. Channel Strategy
10.3.8. PAN Biotech
10.3.8.1. Overview
10.3.8.2. Product and Application Portfolio
10.3.8.3. Production Footprint
10.3.8.4. Sales Footprint
10.3.8.5. Channel Footprint
10.3.8.6. Strategy
10.3.8.6.1.1. Marketing Strategy
10.3.8.6.1.2. Product Strategy
10.3.8.6.1.3. Channel Strategy
10.3.9. MP Biomedicals, LLC
10.3.9.1. Overview
10.3.9.2. Product and Application Portfolio
10.3.9.3. Production Footprint
10.3.9.4. Sales Footprint
10.3.9.5. Channel Footprint
10.3.9.6. Strategy
10.3.9.6.1.1. Marketing Strategy
10.3.9.6.1.2. Product Strategy
10.3.9.6.1.3. Channel Strategy
10.3.10. PromoCell GmbH
10.3.10.1. Overview
10.3.10.2. Product and Application Portfolio
10.3.10.3. Production Footprint
10.3.10.4. Sales Footprint
10.3.10.5. Channel Footprint
10.3.10.6. Strategy
10.3.10.6.1.1. Marketing Strategy
10.3.10.6.1.2. Product Strategy
10.3.10.6.1.3. Channel Strategy

11. Global Serum-Free Media Market Analysis 2013–2017 and Forecast 2018–2026, By Region
11.1. Introduction
11.2. Historical Market Value (US$ Mn) & Volume Analysis By Region, 2013–2017
11.2.1. North America
11.2.2. Latin America
11.2.3. Europe
11.2.4. Asia Pacific
11.2.5. Middle East & Africa
11.3. Market Value (US$ Mn) & Volume By Region, 2018–2026
11.4. Market Attractiveness Analysis By Region

12. Global Serum-Free Media Analysis 2013–2017 and Forecast 2018–2026, By Media Type
12.1. Introduction/Key Findings
12.2. Historical Market Value (US$ Mn) & Volume Analysis By Media Type, 2013–2017
12.2.1. Protein Expression Media
12.2.2. Stem Cell Media
12.2.3. Hybridoma Media
12.2.4. Primary Cell Media
12.2.5. Insect Cell Media
12.2.6. Immunology Media
12.2.7. Chinese Hamster Ovary Cell Culture Media
12.2.8. Chemically Defined Media
12.3. Market Value (US$ Mn) & Volume Forecast By Media Type, 2018–2026
12.4. Market Attractiveness Analysis By Media Type

13. Global Serum-Free Media Market Analysis 2013–2017 and Forecast 2018–2026, By End User
13.1. Introduction/Key Findings
13.2. Historical Market Value (US$ Mn) Trend Analysis By End User, 2013–2017
13.2.1. Biopharmaceutical Companies
13.2.2. Clinical Research Organizations
13.2.3. Academic Research Centers
13.3. Market Value (US$ Mn) Forecast By End User, 2018–2026
13.4. Market Attractiveness Analysis By End User

14. Global Serum-Free Media Market Analysis 2013–2017 and Forecast 2018–2026
14.1. Market Value Share Analysis By All Segment
14.2. Y-o-Y Growth Analysis By All Segment
14.3. Absolute $ Opportunity

15. Research Methodology

List of Tables

Table 01: North America Serum-Free Media Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Media Type
Table 02: North America Serum-Free Media Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User
Table 03: North America Serum-Free Media Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 04: Latin America Serum-Free Media Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Media Type
Table 05: Latin America Serum-Free Media Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User
Table 06: Latin America Serum-Free Media Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 07: Europe Serum-Free Media Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Media Type
Table 08: Europe Serum-Free Media Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User
Table 09: Europe Serum-Free Media Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 10: Asia-Pacific Serum-Free Media Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Media Type
Table 11: Asia-Pacific Serum-Free Media Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User
Table 12: Asia-Pacific Serum-Free Media Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 13: Middle East & Africa Serum-Free Media Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Media Type
Table 14: Middle East & Africa Serum-Free Media Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User
Table 15: Middle East & Africa Serum-Free Media Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 16: Global Serum-Free Media Size (US$ Mn) 2013–2017 and Forecast 2018-2026 By Region,
Table 17: Global Serum-Free Media Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Media Type
Table 18: Global Serum-Free Media Market Value (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User